ClinConnect ClinConnect Logo
Search / Trial NCT00602368

Digital Colposcopy in Finding Cervical Intraepithelial Neoplasia

Launched by BRITISH COLUMBIA CANCER AGENCY · Jan 25, 2008

Trial Information

Current as of May 07, 2025

Completed

Keywords

Cervical Cancer Cervical Intraepithelial Neoplasia Grade 1 Cervical Intraepithelial Neoplasia Grade 2 Cervical Intraepithelial Neoplasia Grade 3

ClinConnect Summary

OBJECTIVES:

* To identify potential improvements for a noninvasive method of diagnosing cervical dysplasia and neoplasia using digital colposcopy and fluorescence spectroscopic imaging.
* To measure fluorescence and reflectance images of the human cervix in vivo using digital colposcopy.
* To evaluate the effect of acetic acid on the image contrast obtained.
* To compare the device performance with colposcopic impression and histopathologic interpretation of tissue removed by standard loop electrosurgical excision procedure (LEEP).

OUTLINE: This is a multicenter study.

Participants under...

Gender

FEMALE

Eligibility criteria

  • Criteria:
  • Inclusion criteria:
  • Included subjects will be ≥18 years old.
  • Included subjects will not be pregnant.
  • Included subjects will have a negative urine pregnancy test.
  • Included subjects will be scheduled for colposcopy and/or LEEP treatment at the VGH Women's Clinic.
  • Included subjects will indicate understanding of the study.
  • Included subjects will provide informed consent to participate.
  • Exclusion criteria:
  • Individuals \<18 years old will be excluded.
  • Pregnant individuals will be excluded.
  • Individuals that have had an operation to remove their cervix will be excluded.
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics

About British Columbia Cancer Agency

The British Columbia Cancer Agency (BCCA) is a leading organization dedicated to cancer research, treatment, and prevention in Canada. As a prominent clinical trial sponsor, BCCA focuses on advancing cancer care through innovative research and the development of new therapeutic strategies. With a commitment to improving patient outcomes, BCCA collaborates with a network of healthcare professionals and research institutions to conduct rigorous clinical trials that explore cutting-edge treatments and diagnostic methods. Their multidisciplinary approach, combined with a strong emphasis on patient-centered care, positions BCCA at the forefront of cancer research and healthcare advancements.

Locations

Vancouver, British Columbia, Canada

Patients applied

0 patients applied

Trial Officials

Dianne M. Miller, M.D.

Principal Investigator

British Columbia Cancer Agency, Vancouver General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials